Peter Ruf
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Oncology top 5%
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 21
- Oncology 16
- CAR-T cell therapy research 12
- Cancer Immunotherapy and Biomarkers 3
- HER2/EGFR in Cancer Research 3
- Co-authors
- Horst Lindhofer (30 shared papers)Michael Jäger (6 shared papers)Juergen Heß (5 shared papers)A. Schoberth (4 shared papers)Jürgen Hess (2 shared papers)Pauline Wimberger (4 shared papers)Ralph Mocikat (5 shared papers)M. M. Heiss (3 shared papers)
In The Last Decade
Peter Ruf
31 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 57
- Radiology, Nuclear Medicine and Imaging 504
- Oncology 555
- Immunology 345
- Biotechnology 46
- Reproductive Medicine 41
Countries citing papers authored by Peter Ruf
This map shows the geographic impact of Peter Ruf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ruf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ruf more than expected).
Fields of papers citing papers by Peter Ruf
This network shows the impact of papers produced by Peter Ruf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ruf. The network helps show where Peter Ruf may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Ruf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 144 | |
| 2 | 2010 | 117 | |
| 3 | 2011 | 94 | |
| 4 | 2007 | 87 | |
| 5 | 2009 | 84 | |
| 6 | 2007 | 78 | |
| 7 | 2010 | 67 | |
| 8 | 2008 | 58 | |
| 9 | 2016 | 56 | |
| 10 | 2003 | 45 | |
| 11 | 2012 | 38 | |
| 12 | 2008 | 34 | |
| 13 | 2012 | 25 | |
| 14 | 2011 | 18 | |
| 15 | 2021 | 16 | |
| 16 | 2015 | 15 | |
| 17 | 2021 | 13 | |
| 18 | 2016 | 10 | |
| 19 | 2011 | 10 | |
| 20 | 2013 | 8 |
About Peter Ruf
Peter Ruf is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Immunology, Surgery and Molecular Biology, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (21 papers), Immunotherapy and Immune Responses (13 papers), CAR-T cell therapy research (12 papers), Cancer Immunotherapy and Biomarkers (3 papers), HER2/EGFR in Cancer Research (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (504 citations), Oncology (555 citations), Immunology (345 citations), Biotechnology (46 citations) and Reproductive Medicine (41 citations). Peter Ruf has collaborated with scholars based in Germany, Romania and Hungary. Frequent co-authors include Horst Lindhofer, Michael Jäger, Juergen Heß, A. Schoberth, Jürgen Hess, Pauline Wimberger, Ralph Mocikat, M. M. Heiss, Nina Eißler and Marc C. Winslet. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, International Journal of Cancer and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.